Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FJJCJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,798
Award facts
- Contract value 100% obligated
- $18,798.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,798.07 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on May 2, 2025, with an ultimate completion date of May 5, 2025. This firm fixed-price, competitively awarded delivery order contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic immunosuppressant commonly prescribed for moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and other allergic conditions, representing a critical specialty pharmaceutical product for military and federal healthcare systems.
This delivery order operates as a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's extensive portfolio of federal contracts and competitive success demonstrates its established capability to meet DLA's pharmaceutical procurement requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FJJCJ?
SPE2DB25FJJCJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 2, 2025.
How much is contract SPE2DB25FJJCJ worth?
The government has obligated $18,798 on SPE2DB25FJJCJ.
Is contract SPE2DB25FJJCJ an order under another contract?
Yes. SPE2DB25FJJCJ is a delivery order under SPE2DB24D2102, an indefinite delivery contract.
Was contract SPE2DB25FJJCJ competed?
The extent of competition for SPE2DB25FJJCJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award